HPV-Related Cervical Carcinoma

Detecting HPV DNA in Anal and Cervical Cancers

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

HPV in Sentinel Lymph Nodes of Cervical Cancer Patients

Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis

Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

Self-collected Vaginal and Urine Samples in HIV-positive Women

Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial

Dry Run of the ScreenUrSelf Trial

STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

CASUS: Validation for Detection of Precursor Lesions

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)